Oral nicotinamide reduced the risk of new skin cancers—especially squamous cell carcinoma—by up to 54% when started after a ...

Up to 32% lower risk conferred by early initiation, while increased risk for dementia seen in studies among older women.

Risks for developing Alzheimer’s disease can increase or decrease depending on when women begin hormone replacement therapy, ...

The timing of hormone replacement therapy may make a big difference in a woman's risk of developing Alzheimer's disease.

A new study recently put this popular eating plan to the test —  and the results were surprising. Here’s what you need to know.

Erratum: Randomized, Open-Label, Phase III Study of Tilsotolimod in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced Refractory Melanoma (ILLUMINATE-301) The trials were ...

Baylor College of Medicine has received new funding from the National Institutes of Health for two consortia in the Rare ...